Transmission-blocking vaccines are increasingly being developed to elicit human antigametocyte antibodies that block early stages of parasite growth during the mosquito. This kind of vaccines, when used in a mix with other vaccines, may possibly lengthen their effective life by lessening the rate at which variant forms of parasites show up. Each Th